Top Markets
Coin of the day
TWi Biotechnology, Inc. TWi Biotechnology, Inc.

TWi Biotechnology, Inc.

6610
Clasificación en acciones #17309
TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm,... TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating on the development and sale of medications designed to address innate immunity disorders, primarily within Taiwan. The company's drug pipeline notably includes AC-203, which is currently undergoing Phase 2 clinical trials for various conditions such as epidermolysis bullosa simplex, epidermolysis bullosa, arthritis, gout, and diabetes mellitus. Additionally, AC-1101 is in Phase 1 trials for vitiligo treatment and is advancing through preclinical stages for atopic dermatitis, granuloma annulare, and other uncommon autoimmune skin diseases. TWi Biotechnology has also established a drug development collaboration with Hong Kong Winhealth Pharma Group Co., Limited, targeting the markets of Mainland China, Hong Kong, and Macao. Founded in 2010, the company is headquartered in Taipei, Taiwan.
Precio por acción
$1.21
Capitalización bursátil
$248.41M
Cambio (1 día)
4.11%
Cambio (1 año)
79.12%
País
TW
Comercio TWi Biotechnology, Inc. (6610)

Categoría

Historial de desdoblamientos de acciones de TWi Biotechnology, Inc. (6610)
La acción TWi Biotechnology, Inc. (símbolo: 6610) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Sep 02, 2026.
Una acción 6610 comprada antes de Sep 02, 2026 equivaldría hoy a 0 acciones 6610.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH